Through the myocardial infarction model developed, it demonstrated nebivolol’s enhancement of NO-mediated effects such as the prevention of nitrosative damages through the reduction in the activity of iNOS, preservation of the glomerular filtration rate through neuronal NOS (nNOS), and restoration of eNOS in the late period of MI. The gene discussed is NOS2; the disease is myocardial infarction.